| Record ID | marc_oregon_summit_records/catalog_files/osu_bibs.mrc:669892531:1454 |
| Source | Oregon Libraries |
| Download Link | /show-records/marc_oregon_summit_records/catalog_files/osu_bibs.mrc:669892531:1454?format=raw |
LEADER: 01454cam a2200397 i 4500
001 3527997
003 OR
008 940418s1977 mdu b f000 0 eng d
020 $cpbk.
035 $a10696984
040 $aHEW$cHEW$dGPO$dMvI
049 $aORE1$lbna
074 $a507-G-12
086 $aHE 20.3159/2:45
086 $aHE 20.3159/2:45
099 $aHE 20.3159/2:45
110 2 $aNational Cancer Institute (U.S.).$bDivision of Cancer Cause and Prevention.
245 10 $aBioassay of chlorpropamide for possible carcinogenicity.
260 $aBethesda, Md. :$bDept. of Health, Education, and Welfare, Public Health Service, National Institutes of Health, National Cancer Institute, Division of Cancer Cause and Prevention, Carcinogenesis Testing Program,$c1977.
300 $axi, 86 p. :$bill. ;$c27 cm.
490 1 $aDHEW publication ; no. (NIH) 78-845.
490 1 $aCarcinogenesis technical report series ; no. 45.
500 $a"CAS no. 94-20-2."
504 $aBibliography: p. 35-36.
650 0 $aCarcinogens.
650 0 $aHypoglycemic agents.
650 0 $aPoisons.
650 0 $aToxicology.
810 2 $aNational Cancer Institute (U.S.).$tCarcinogenesis technical report series ;$vno. 45.
830 0 $aDHEW publication ;$vno. (NIH) 78-845.
907 $a.b16360825$bvdo $c-
902 $a990521
998 $b1$c981001$dm$ea$f-$g0
937 $aAssessment exclusion record.
999 $a19940418050255.0
945 $lvdog $e1